JP2024542989A5 - - Google Patents
Info
- Publication number
- JP2024542989A5 JP2024542989A5 JP2024525152A JP2024525152A JP2024542989A5 JP 2024542989 A5 JP2024542989 A5 JP 2024542989A5 JP 2024525152 A JP2024525152 A JP 2024525152A JP 2024525152 A JP2024525152 A JP 2024525152A JP 2024542989 A5 JP2024542989 A5 JP 2024542989A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation according
- sequence
- antibody
- formulation
- arg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SG10202112096R | 2021-10-29 | ||
| SG10202112096R | 2021-10-29 | ||
| US202263332737P | 2022-04-20 | 2022-04-20 | |
| US63/332,737 | 2022-04-20 | ||
| SG10202250847P | 2022-08-29 | ||
| SG10202250847P | 2022-08-29 | ||
| PCT/SG2022/050779 WO2023075700A1 (en) | 2021-10-29 | 2022-10-28 | Anti-il-13r antibody formulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024542989A JP2024542989A (ja) | 2024-11-19 |
| JP2024542989A5 true JP2024542989A5 (https=) | 2025-10-31 |
Family
ID=84536171
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024525152A Pending JP2024542989A (ja) | 2021-10-29 | 2022-10-28 | 抗ｉｌ－１３ｒ抗体製剤 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250325475A1 (https=) |
| EP (1) | EP4422684A1 (https=) |
| JP (1) | JP2024542989A (https=) |
| TW (1) | TW202332466A (https=) |
| WO (1) | WO2023075700A1 (https=) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112012027828A2 (pt) * | 2010-05-03 | 2016-08-09 | Genentech Inc | composição de matéria, artigo de fabricação e método de redução da viscosidade de uma formulação contendo proteína e de preparação de uma formulação aquosa contendo proteína |
| CN113677708A (zh) * | 2019-03-26 | 2021-11-19 | 亚狮康私人有限公司 | 采用抗il13r抗体或其结合片段的治疗 |
-
2022
- 2022-10-28 EP EP22823643.6A patent/EP4422684A1/en active Pending
- 2022-10-28 WO PCT/SG2022/050779 patent/WO2023075700A1/en not_active Ceased
- 2022-10-28 TW TW111141149A patent/TW202332466A/zh unknown
- 2022-10-28 JP JP2024525152A patent/JP2024542989A/ja active Pending
- 2022-10-28 US US18/705,569 patent/US20250325475A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020518598A5 (https=) | ||
| JP2023109942A5 (https=) | ||
| EP3277719B1 (en) | Polypeptides | |
| JP2023515271A5 (https=) | ||
| EP3277713B1 (en) | Polypeptides | |
| JP2012513214A5 (https=) | ||
| JP2021512881A5 (https=) | ||
| EP3061818B1 (en) | Anti-lps o11 antibody | |
| KR20230016186A (ko) | 갈렉틱-3 차단에 의한 염증성 질환의 치료 방법 | |
| JP2005530845A (ja) | 抗体を濃縮するための緩衝化処方物およびその使用方法 | |
| JP2018526369A (ja) | バイオ医薬組成物 | |
| WO2020124846A1 (zh) | 抗呼吸道合胞病毒的中和抗体及其应用 | |
| CN113677708A (zh) | 采用抗il13r抗体或其结合片段的治疗 | |
| JP2023513833A5 (https=) | ||
| JP2019501139A5 (https=) | ||
| JP2021511024A5 (https=) | ||
| WO2005035574A1 (ja) | IgM高濃度安定化溶液 | |
| US11472872B2 (en) | Antibody variants | |
| JP2024542989A5 (https=) | ||
| WO2019230869A1 (ja) | 抗ヒトｔｌｒ７抗体 | |
| TWI873084B (zh) | 抗體變異體 | |
| TW202320847A (zh) | 一種抗ａｎｇｐｔｌ３抗體或其抗原結合片段的醫藥組成物及其用途 | |
| CN114828888A (zh) | 用于结合纤溶酶原的抗体 | |
| JP2022529996A5 (https=) | ||
| JP2025503707A5 (https=) |